Holen Sie sich die Stockscreener-App
14.41
3.22%
0.45
Handel nachbörslich:
14.34
-0.07
-0.49%
Schlusskurs vom Vortag:
$13.96
Offen:
$14
24-Stunden-Volumen:
830.39K
Relative Volume:
0.61
Marktkapitalisierung:
$910.84M
Einnahmen:
$492.05M
Nettoeinkommen (Verlust:
$197.92M
KGV:
6.2652
EPS:
2.3
Netto-Cashflow:
$176.12M
1W Leistung:
+1.12%
1M Leistung:
+8.51%
6M Leistung:
-15.58%
1J Leistung:
-18.82%
1-Tages-Spanne:
$14.00
$14.47
1-Wochen-Bereich:
$13.86
$14.47
52-Wochen-Spanne:
$13.14
$19.85
Inmode Ltd Stock (INMD) Company Profile
Vergleichen Sie INMD mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
INMD
Inmode Ltd
|
14.41 | 868.09M | 492.05M | 197.92M | 176.12M | 2.30 |
|
ABT
Abbott Laboratories
|
125.73 | 228.77B | 43.11B | 13.98B | 6.66B | 7.98 |
|
BSX
Boston Scientific Corp
|
103.16 | 153.09B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
395.15 | 149.27B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
91.65 | 114.31B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
76.30 | 45.06B | 5.54B | 4.18B | 623.10M | 7.00 |
Inmode Ltd Stock (INMD) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-04-29 | Herabstufung | BTIG Research | Buy → Neutral |
| 2025-04-28 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2024-10-17 | Eingeleitet | BTIG Research | Buy |
| 2024-07-23 | Herabstufung | Jefferies | Buy → Hold |
| 2023-11-03 | Herabstufung | UBS | Buy → Neutral |
| 2023-10-13 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2023-03-29 | Eingeleitet | UBS | Buy |
| 2023-02-17 | Herabstufung | Needham | Buy → Hold |
| 2022-12-21 | Eingeleitet | Barclays | Overweight |
| 2022-10-12 | Eingeleitet | Jefferies | Buy |
| 2021-05-25 | Eingeleitet | Barclays | Overweight |
| 2021-05-18 | Eingeleitet | Needham | Buy |
| 2019-09-03 | Eingeleitet | Barclays | Overweight |
| 2019-09-03 | Eingeleitet | Canaccord Genuity | Buy |
| 2019-09-03 | Eingeleitet | Robert W. Baird | Outperform |
| 2019-09-03 | Eingeleitet | UBS | Buy |
Alle ansehen
Inmode Ltd Aktie (INMD) Neueste Nachrichten
What drives InMode Ltd. stock priceRapidly growing investment returns - jammulinksnews.com
InMode Ltd. Stock Analysis and ForecastExplosive portfolio gains - jammulinksnews.com
What analysts say about InMode Ltd. stockFree Stock Market Trend Analysis - Autocar Professional
Is InMode Ltd. a good long term investmentFree Capital Efficiency Planning - jammulinksnews.com
What makes InMode Ltd. stock price move sharplyProtected Capital Trading Plan - beatles.ru
When (INMD) Moves Investors should Listen - news.stocktradersdaily.com
Canaccord Genuity Maintains a Hold Rating on InMode Ltd. (INMD) - MSN
InMode Ltd.'s (NASDAQ:INMD) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock? - simplywall.st
InMode Launches Triton in Australia: A New Era in Laser Hair Removal - medianet.com.au
InMode: Margin Pressure, But Optionality Makes It Worth A Look (NASDAQ:INMD) - Seeking Alpha
InMode to Report Second Quarter 2025 Financial Results and Hold Conference Call on July 30, Expects Q2 Revenue Between $95.4M-$95.5M, Decreases Full Year 2025 Revenue Guidance to be Between $365M-$375M - Kilgore News Herald
InMode stock falls as BTIG maintains Neutral rating amid lowered guidance - Investing.com Canada
InMode Cuts Fiscal 2025 Revenue Outlook - MarketScreener
InMode Ltd. Revises Revenue Guidance for the Full Year 2025 - MarketScreener
Inmode Ltd. Provides Revenue Guidance for the Second Quarter of 2025 - MarketScreener
InMode to Report Second Quarter 2025 Financial Results and Hold Conference Call on July 30, Expects Q2 Revenue Between $95.4M-$95.5M, Decreases Full Year 2025 Revenue Guidance to be Between $365M-$375 - StreetInsider
InMode India Launches IgniteRFDr. Harvinder & Dr. Gurjot Marwah Become First in India to Pioneer RF Aesthetic Technology - ANI News
(INMD) Technical Pivots with Risk Controls - news.stocktradersdaily.com
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of April 15, 2024 in InMode LawsuitINMD - ACCESS Newswire
Is InMode Ltd. overvalued or undervalued? - MarketsMojo
InMode wins case against DHGate sellers over counterfeit products - MSN
InMode Ltd. (INMD): A Volatile Play on Institutional Sentiment and Ownership Risk - AInvest
(INMD) Investment Analysis - news.stocktradersdaily.com
Institutional owners may consider drastic measures as InMode Ltd.'s (NASDAQ:INMD) recent US$51m drop adds to long-term losses - simplywall.st
Earnings Are Growing at InMode (NASDAQ:INMD) but Shareholders Still Don't Like Its Prospects - 富途牛牛
InMode Ltd (INMD) Stock Price Up 3.46% on Jun 9 - GuruFocus
Inmode Ltd (INMD): Is This Deeply Undervalued Stock a Hidden Gem? - The Acquirer's Multiple
InMode at Jefferies Conference: Navigating Economic Challenges By Investing.com - Investing.com South Africa
InMode at Jefferies Conference: Navigating Economic Challenges - Investing.com Australia
(INMD) On The My Stocks Page - news.stocktradersdaily.com
Millennium Management LLC Acquires 35,536 Shares of InMode Ltd. (NASDAQ:INMD) - Defense World
Nuveen Asset Management LLC Reduces Holdings in InMode Ltd. (NASDAQ:INMD) - Defense World
InMode CEO addresses shareholder concerns on operations By Investing.com - Investing.com South Africa
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Has $689,000 Stake in InMode Ltd. (NASDAQ:INMD) - Defense World
InMode Response Letter to DOMA by Moshe Mizrahy, CEO, Dated May 28, 2025 - GuruFocus
InMode CEO addresses shareholder concerns on operations - Investing.com Australia
Finanzdaten der Inmode Ltd-Aktie (INMD)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.64%
0.34%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):